Thomas Chalopin

Tours, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Observation of emergent scaling of spin-charge correlations at the onset of the pseudogap.

Observation of emergent scaling of spin-charge correlations at the onset of the pseudogap.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: January 23, 2026

The Value of Progression-Free Survival in the Perspective of Patients with Multiple Myeloma and Treating Physicians: Research Findings from the US, EU4, UK, Brazil, and Japan.

The Value of Progression-Free Survival in the Perspective of Patients with Multiple Myeloma and Treating Physicians: Research Findings from the US, EU4, UK, Brazil, and Japan.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 06, 2026

Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France.

Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France.

Journal: Clinical hematology international

Published: December 04, 2025

Non-Gaussian statistics of the order parameter across a phase transition.

Non-Gaussian statistics of the order parameter across a phase transition.

Journal: Nature

Published: July 21, 2025

35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.

35 years of academic trials focusing on high-dose therapy and autologous stem cell transplantation: the Intergroupe Francophone du Myélome (IFM) experience.

Journal: Blood cancer journal

Published: July 07, 2025

The Impact of Anti-CD38 Monoclonal Antibodies in Frontline Therapy for Patients With Newly Diagnosed Multiple Myeloma: Real-Life Results From the EMMY Study.

The Impact of Anti-CD38 Monoclonal Antibodies in Frontline Therapy for Patients With Newly Diagnosed Multiple Myeloma: Real-Life Results From the EMMY Study.

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 03, 2025

High-fidelity collisional quantum gates with fermionic atoms.

High-fidelity collisional quantum gates with fermionic atoms.

Journal: Nature

Published: June 19, 2025

Debulking strategy prior to anti-BCMA/CD3 bispecific antibodies in extramedullary and/or high tumor burden RRMM: a retrospective cohort study.

Debulking strategy prior to anti-BCMA/CD3 bispecific antibodies in extramedullary and/or high tumor burden RRMM: a retrospective cohort study.

Journal: Blood cancer journal

Published: June 07, 2025

Measurable Residual Disease-Guided Therapy in Newly Diagnosed Myeloma.

Measurable Residual Disease-Guided Therapy in Newly Diagnosed Myeloma.

Journal: The New England journal of medicine

Published: June 03, 2025

Real-World Utilization of Carfilzomib (Once or Twice Weekly) Initiated in Patients After a First Relapse Between 2017 and 2022 in France: An Analysis From a Large-Scale Epidemiology of Multiple MYeloma (EmmY) Cohort.

Real-World Utilization of Carfilzomib (Once or Twice Weekly) Initiated in Patients After a First Relapse Between 2017 and 2022 in France: An Analysis From a Large-Scale Epidemiology of Multiple MYeloma (EmmY) Cohort.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 18, 2025

Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial.

Response profile and long-term outcomes in Cyclin D1-overexpressing multiple myeloma: insights from the CASSIOPEIA trial.

Journal: Blood cancer journal

Published: April 05, 2025

Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study.

Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study.

Journal: Haematologica

Published: April 04, 2025

Showing 1-12 of 45

Last Updated: 09/26/2026